Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Katherine A. B. Kellett"'
Autor:
Isobel J Whitehouse, Deborah Brown, Herbert Baybutt, Abigail B Diack, Katherine A B Kellett, Pedro Piccardo, Jean C Manson, Nigel M Hooper
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159119 (2016)
The cellular prion protein (PrPC) has been proposed to play an important role in the pathogenesis of Alzheimer's disease. In cellular models PrPC inhibited the action of the β-secretase BACE1 on wild type amyloid precursor protein resulting in a red
Externí odkaz:
https://doaj.org/article/661eb766a5da451a8aa047e01b1089fe
Publikováno v:
Neuronal Signaling
The neurovascular unit (NVU), consisting of neurons, glial cells, vascular cells (endothelial cells, pericytes and vascular smooth muscle cells (VSMCs)) together with the surrounding extracellular matrix (ECM), is an important interface between the p
Autor:
Catherine B. Lawrence, Lana Papafilippou, James Eales, Marilena Hadjidemetriou, Kostas Kostarelos, Nigel M. Hooper, Jack Rivers-Auty, Katherine A. B. Kellett
Publikováno v:
Hadjidemetriou, M, Rivers-Auty, J, Papafilippou, L, Eales, J, Kellett, K A B, Hooper, N M, Lawrence, C B & Kostarelos, K 2021, ' Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease ', ACS Nano, vol. 15, no. 4, pp. 7357-7369 . https://doi.org/10.1021/acsnano.1c00658
ACS Nano
Papafilippou, T A, Hadjidemetriou, M, Kostarelos, K, Rivers-Auty, J, Hooper, N, Lawrence, C B & Eales, J 2021, ' Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease ', ACS Nano, pp. 7357–7369 . https://doi.org/10.1021/acsnano.1c00658
ACS Nano
Papafilippou, T A, Hadjidemetriou, M, Kostarelos, K, Rivers-Auty, J, Hooper, N, Lawrence, C B & Eales, J 2021, ' Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease ', ACS Nano, pp. 7357–7369 . https://doi.org/10.1021/acsnano.1c00658
Blood-circulating biomarkers have the potential to detect Alzheimer's disease (AD) pathology before clinical symptoms emerge and to improve the outcomes of clinical trials for disease-modifying therapies. Despite recent advances in understanding conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd859d253447b068f05de39842ece6e3
https://doi.org/10.1021/acsnano.1c00658
https://doi.org/10.1021/acsnano.1c00658
Autor:
Isobel J Whitehouse, J Scott Miners, Elizabeth B C Glennon, Patrick G Kehoe, Seth Love, Katherine A B Kellett, Nigel M Hooper
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e59554 (2013)
The cellular prion protein (PrP(C)) has been implicated in the development of Alzheimer's disease (AD). PrP(C) decreases amyloid-β (Aβ) production, which is involved in AD pathogenesis, by inhibiting β-secretase (BACE1) activity. Contactin 5 (CNTN
Externí odkaz:
https://doaj.org/article/ee16e95ab5754226969dbd39ff64f1cc
Autor:
Elizabeth B C Glennon, Isobel J Whitehouse, J Scott Miners, Patrick G Kehoe, Seth Love, Katherine A B Kellett, Nigel M Hooper
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e78806 (2013)
Bridging integrator 1 (BIN1) has been implicated in sporadic Alzheimer's disease (AD) by a number of genome wide association studies (GWAS) in a variety of populations. Here we measured BIN1 in frontal cortex samples from 24 sporadic AD and 24 age-ma
Externí odkaz:
https://doaj.org/article/ef52b105705747f99d93a0f22f859fb6
Publikováno v:
Neurochemical Research
Rowland, H, Hooper, N & Kellett, K 2018, ' Modelling Sporadic Alzheimer’s Disease using Induced Pluripotent Stem Cells ', Neurochemical research . https://doi.org/10.1007/s11064-018-2663-z
Rowland, H, Hooper, N & Kellett, K 2018, ' Modelling Sporadic Alzheimer’s Disease using Induced Pluripotent Stem Cells ', Neurochemical research . https://doi.org/10.1007/s11064-018-2663-z
Developing cellular models of sporadic Alzheimer’s disease (sAD) is challenging due to the unknown initiator of disease onset and the slow disease progression that takes many years to develop in vivo. The use of human induced pluripotent stem cells
Autor:
Katherine A. B. Kellett, Sikha Saha, Nadira Yuldasheva, Alasdair R. Pickles, Sabah Khan, Trevor F.C. Batten
Publikováno v:
Neurochemistry International. 118:134-144
Cerebral ischemia is known to be a major cause of death and the later development of Alzheimer's disease and vascular dementia. However, ischemia induced cellular damage that initiates these diseases remain poorly understood. This is primarily due to
Publikováno v:
Andrew, R J, Kellett, K, Thinakaran, G & Hooper, N 2016, ' A Greek Tragedy: the Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis ', Journal of Biological Chemistry, vol. 291, pp. 19235-19244 . https://doi.org/10.1074/jbc.R116.746032
Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-associated dysfunctions, amyloid-β. However, recent evidence suggests that the accepted view of APP proteolysis by t
Autor:
Daniel S. Greenspan, Kate Fisher, Sreemoti Banerjee, Catherine B. Lawrence, Carolyn D. Jackson, Katherine A. B. Kellett, Christopher J. Duff, Nobuyo Maeda, Nigel M. Hooper, Robert J. Andrew
Publikováno v:
Scientific Reports
Banerjee, S, Andrew, R J, Duff, C J, Fisher, K, Jackson, C D, Lawrence, C B, Maeda, N, Greenspan, D S, Kellett, K & Hooper, N 2019, ' Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake ', Scientific Reports . https://doi.org/10.1038/s41598-019-47814-0
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Banerjee, S, Andrew, R J, Duff, C J, Fisher, K, Jackson, C D, Lawrence, C B, Maeda, N, Greenspan, D S, Kellett, K & Hooper, N 2019, ' Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake ', Scientific Reports . https://doi.org/10.1038/s41598-019-47814-0
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
The development of cardiovascular disease is intimately linked to elevated levels of low-density lipoprotein (LDL) cholesterol in the blood. Hepatic LDL receptor (LDLR) levels regulate the amount of plasma LDL. We identified the secreted zinc metallo
Autor:
Satyan Chintawar, Sally A. Cowley, Helen A. Rowland, Heledd H. Jarosz-Griffiths, Nigel M. Hooper, Gareth Howell, M. Zameel Cader, Katherine A. B. Kellett, Jennifer Baron, Kate Fisher, Nicola J. Corbett, Alys C. Jones
Publikováno v:
The Journal of Biological Chemistry
The cellular prion protein (PrPC) is a key neuronal receptor for β-amyloid oligomers (AβO), mediating their neurotoxicity, which contributes to the neurodegeneration in Alzheimer's disease (AD). Similarly to the amyloid precursor protein (APP), PrP